The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.

You can also contact the CTN coordinating centre for additional information:

Study Name on (link is external)
A study of safety, tolerability and effect of SNSP113 in Cystic Fibrosis
Study DrugSNSP113 
Type of Study DrugAnti-infective
Study TitleA Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Effect of Inhaled SNSP113 in Adult Subjects with Cystic Fibrosis 
Study Phase2
Study SponsorSynspira

Link on (link is external)

Participating ECFS-CTN sitesPlease contact for most recent sitelist
Age18 Years and older